Therapeutic Focus: <em>Drop</em>ping Some Knowledge
Vizz (aceclidine ophthalmic solution) 1.44%, from Lenz Therapeutics, offers spectacle-free vision and the opportunity to secure patient loyalty.
-
By
-
Julie Greenbaum, editor
-
January 1, 2026
-
-
1
Vizz (aceclidine ophthalmic solution) 1.44% provides spectacle-free vision and enhances patient loyalty through improved quality of life.
-
2
The eye drop improves near vision within 30 minutes and lasts up to 10 hours by contracting the iris sphincter muscle.
-
3
Patients appreciate Vizz for its functional vision and aesthetic benefits, avoiding the need for reading glasses.
-
4
Vizz supports contact lens wearers by offering a solution for near vision, helping retain patients who might otherwise drop out.
-
5
Managing patient expectations regarding mild side effects is crucial for successful adoption of Vizz in clinical practice.